Abstract: Disclosed is an ergonomic device for mixing fluids with controlled metering, provided with at least a mixing system adapted to allow an automatic mixing in predetermined quantities of an additive fluid with a primary fluid. The device includes: at least a first coupling flange and a second coupling flange, provided with a plurality of connection systems, which may be located in the zone, and seals adapted to contain fluid leaks; a substantially cylindrical body of the device adapted to house a mixing system; a mixing mechanism consisting of an axis and a plurality of blades; at least one ergonomic grip; possibly an integrated train of reduction gears which transmits the correct torque and number of revolutions to the pump; at least one gear pump or equivalent device; possibly a gearbox; and a final metering nozzle.

Abstract: The present invention relates to a hydrophobic polymer used in particular to produce and/or coat medical devices, in particular implantable medical devices, that are visible in magnetic resonance imaging, characterized in that it comprises at least one monomer unit on which is grafted a chelating ligand of a paramagnetic ion complexed with such a paramagnetic ion, said monomer unit having at least one carbonyl group, said monomer unit comprising, prior to grafting, at least one hydrogen atom in the ? position of said at least one carbonyl group, and said grafting of the chelating ligand taking place in the area of said at least one hydrogen atom in the ? position of said at least one carbonyl group.

Abstract: The present invention relates to a hydrophobic polymer used in particular to produce and/or coat medical devices, in particular implantable medical devices, that are visible in magnetic resonance imaging, characterized in that it comprises at least one monomer unit on which is grafted a chelating ligand of a paramagnetic ion complexed with such a paramagnetic ion, said monomer unit having at least one carbonyl group, said monomer unit comprising, prior to grafting, at least one hydrogen atom in the a position of said at least one carbonyl group, and said grafting of the chelating ligand taking place in the area of said at least one hydrogen atom in the a position of said at least one carbonyl group.